Peter Boström - UTU Research Portal

Peter Boström

- Professor,
Surgery (Department of Clinical Medicine)

peter.bostrom@utu.fi

: https://orcid.org/0000-0003-3647-0015

8 of 24

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression (2022)
- Cancers
Yu Lan, Toriseva Mervi, Afshan Syeda, Cangiano Mario, Fey Vidal, Erickson Andrew, Seikkula Heikki, Alanen Kalle, Taimen Pekka, Ettala Otto, Nurmi Martti, Boström Peter J, Kallajoki Markku, Tuomela Johanna, Mirtti Tuomas, Beumer Inès J, Nees Matthias, Härkönen Pirkko
Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)
- BMJ Open
Ettala Otto, Jambor Ivan, Perez Ileana Montoya, Seppänen Marjo, Kaipia Antti, Seikkula Heikki, Syvänen Kari T, Taimen Pekka, Verho Janne, Steiner Aida, Saunavaara Jani, Saukko Ekaterina, Löyttyniemi Eliisa, Sjoberg Daniel D, Vickers Andrew, Aronen Hannu, Boström Peter
Integrins are enriched on aberrantly fucosylated tumour‐derived urinary extracellular vesicles (2022)
- Journal of Extracellular Biology
Islam Md. Khirul, Dhondt Bert, Syed Parvez, Khan Misba, Gidwani Kamlesh, Webber Jason, Hendrix An, Jenster Guido, Lamminen Tarja, Boström Peter J, Pettersson Kim, Lamminmäki Urpo, Leivo Janne
Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study (2022)
- BJU International
Viitala Antti, Anttinen Mikael, Wright Cameron, Virtanen Ilari, Mäkelä Pietari, Hovinen Topi, Sainio Teija, Saunavaara Jani, Taimen Pekka, Sequeiros Roberto Blanco, Boström Peter J
Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study (2022)
- World Journal of Urology
Salmivalli Alisa, Ettala Otto, Boström Peter J, Kytö Ville
Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019 (2022)
- Acta Oncologica
Seikkula Heikki, Kaipia Antti, Boström Peter J., Malila Nea, Pitkäniemi Janne, Seppä Karri
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score (2022)
- European Urology
Peters Max, Eldred-Evans David, Kurver Piet, Falagario Ugo Giovanni, Connor Martin J., Shah Taimur T., Verhoeff Joost J.C., Taimen Pekka, Aronen Hannu J., Knaapila Juha, Montoya Perez Ileana, Ettala Otto, Stabile Armando, Gandaglia Giorgio, Fossati Nicola, Martini Alberto, Cucchiara Vito, Briganti Alberto, Lantz Anna, Picker Wolfgang, Haug Erik Skaaheim, Nordström Tobias, Tanaka Mariana Bertoncelli, Reddy Deepika, Bass Edward, van Rossum Peter S.N., Wong Kathie, Tam Henry, Winkler Mathias, Gordon Stephen, Qazi Hasan, Boström Peter J., Jambor Ivan, Ahmed Hashim U.
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients (2022)
- Urologic Oncology: Seminars and Original Investigations
Mertens Laura S., Claps Francesco, Mayr Roman, Bostrom Peter J., Shariat Shahrok F., Zwarthoff Ellen C., Boormans Joost L., Abas Cheno, van Leenders Geert J.L.H., Götz Stefanie, Hippe Katrin, Bertz Simone, Neuzillet Yann, Sanders Joyce, Broeks Annegien, Peters Dennis, van der Heijden Michiel S., Jewett Michael A.S., Stöhr Robert, Zlotta Alexandre R., Eckstein Markus, Soorojebally Yanish, van der Schoot Deric K.E., Wullich Bernd, Burger Maximilian, Otto Wolfgang, Radvanyi François, Sirab Nanour, Pouessel Damien, van der Kwast Theo H., Hartmann Arndt, Lotan Yair, Allory Yves, Zuiverloon Tahlita C.M., van Rhijn Bas W.G.
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol (2022)
- BMJ Open
Siltari Aino, Riikonen Jarno, Koskimäki Juha, Pakarainen Tomi, Ettala Otto, Boström Peter, Seikkula Heikki, Kotsar Andres, Tammela Teuvo, Helminen Mika, Raittinen Paavo V, Lehtimäki Terho, Fode Mikkel, Østergren Peter, Borre Michael, Rannikko Antti, Marttila Timo, Salonen Arto, Ronkainen Hanna, Löffeler Sven, Murtola Teemu J
The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator (2022)
- European Urology Open Science
Parekh Sneha, Ratnani Parita, Falagario Ugo, Lundon Dara, Kewlani Deepshikha, Nasri Jordan, Dovey Zach, Stroumbakis Dimitrios, Ranti Daniel, Grauer Ralph, Sobotka Stanislaw, Pedraza Adriana, Wagaskar Vinayak, Mistry Lajja, Jambor Ivan, Lantz Anna, Ettala Otto, Stabile Armando, Taimen Pekka, Aronen Hannu J, Knaapila Juha, Perez Ileana Montoya, Gandaglia Giorgio, Martini Alberto, Picker Wolfgang, Haug Erik, Cormio Luigi, Nordström Tobias, Briganti Alberto, Boström Peter J, Carrieri Giuseppe, Haines Kenneth, Gorin Michael A, Wiklund Peter, Menon Mani, Tewari Ash